SP1 and non-small cell lung carcinoma: More evidence comes from an investigation by Chang et colleagues [2], who showed that when BMI1 is overexpressed, miR-145 is downregulated, which boosts Sp1 expression and triggers EMT in pemetrexed-resistant NSCLC cells [2].